Concepedia

Bita Fakhri

BF

26

Publications

1.5K

Citations

16

H-Index

2007

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Memorial Sloan Kettering Cancer Center

Fred Hutch Cancer Center

University of California, San Francisco

University of Pennsylvania

Bita Fakhri is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and pathology.

Top concepts

MedicineOncologyPathologyCancer ResearchHematologyImmunologyRadiation OncologyHealthImmunotherapyAllergy

Publications per year

2007–2024

26

Publications

26

Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study

Anthony R. Mato, Nirav N. Shah, Wojciech Jurczak et al. · The Lancet · 2021 · 432 citations · Full text

Phase 1/2, Lymphoid Neoplasia, Medicine +6

Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia

Anthony R. Mato, Jennifer A. Woyach, Jennifer R. Brown et al. · New England Journal of Medicine · 2023 · 190 citations · Full text

Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1–2 study

Tanya Siddiqi, David G. Maloney, Saad S. Kenderian et al. · The Lancet · 2023 · 174 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Transcend Cll 004 +9

NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021

Andrew D. Zelenetz, Leo I. Gordon, Julie Chang et al. · Journal of the National Comprehensive Cancer Network · 2021 · 164 citations · Full text

Hematological Malignancy, Nccn Guidelines® Insights, Lymphoid Neoplasia +15

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024

William G. Wierda, Jennifer R. Brown, Jeremy S. Abramson et al. · Journal of the National Comprehensive Cancer Network · 2024 · 72 citations · Full text

Rows per page

1–5 of 26